Research
Cellular
Gastrointestinal side effects were more common with GI181771X than with placebo treatment.
Clinicians should monitor for gastrointestinal side effects in patients taking GI181771X.
StrongSupportsmedium confidence
Gastrointestinal side effects were more common with GI181771X than with placebo treatment.
Why this rating
Based on the randomized controlled trial design with a large sample size.
Source
Stimulation of Cholecystokinin-A Receptors With GI181771X does not Cause Weight Loss in Overweight or Obese Patients
Jens Jordan et al. · Clinical Pharmacology & Therapeutics · 2007
DOI 10.1038/sj.clpt.6100272
rct · n=701Cited 118×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Cellular
- Athletes aiming to reduce fat mass and preserve FFM should consume protein intakes in the range of ∼1.8-2.7 g kg(-1) d(-1).Strong
- A minimum daily protein intake of ≥1.6 g/kg is necessary to observe significant improvements in muscle mass from whey protein supplementation.Strong
- Most athletes ideally need 1.2 to 2.0 grams/kg of body weight/day of protein, preferably split across 3-4 meals.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →